To Assess Safety and Efficacy of Agents Targeting DNA Damage Repair With Olaparib Versus Olaparib Monotherapy.
Clinical trial NCT03330847 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03330847
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-07
- Primary completion
- 2020-11-13
- Enrollment
- 273
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.